Improved growth velocity during thyroid hormone therapy in children with Fanconi anemia and borderline thyroid function

Pediatric Blood and Cancer

Volumn 51, Issue 5, 2008, Pages 652-656

  Eyal, Ori ^a   Blum, Samantha ^a   Mueller, Robin ^b   Smith, Franklin O ^b   Rose, Susan R ^a,c  

^a UNIVERSITY OF CINCINNATI   (United States)

^b Fanconi Anemia Comprehensive Care Center   (United States)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Fanconi anemia; Primary hypothyroidism; Short stature

Indexed keywords

LEVOTHYROXINE; THYROID HORMONE; THYROTROPIN; THYROXINE;

ADOLESCENT; ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG SAFETY; FANCONI ANEMIA; FEMALE; GROWTH RATE; HORMONAL THERAPY; HUMAN; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THYROID DISEASE; THYROID FUNCTION TEST;

CHILD; CHILD, PRESCHOOL; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FANCONI ANEMIA; FEMALE; GROWTH; GROWTH DISORDERS; HUMANS; MALE; THYROID FUNCTION TESTS; THYROXINE;

EID: 52249121162     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21673     Document Type: Article

References (23)

1. Wajnrajch MP, Gertner JM, Huma Z, et al. Evaluation of growth and hormonal status in patients referred to the International Fanconi Anemia Registry. Pediatrics 2001;107:744-745.
2. Wadwa RP, Rose SR, Eaton ME. The Fanconi Anemia Comprehensive Care Center. Endocrine effects of Fanconi anemia. Pediatr Res 2003;52.
3. Giri N, Batista DL, Alter BP, et al. Endocrine abnormalities in patients with Fanconi anemia. J Clin Endocrinol Metab 2007;92:2624-2631.
4. Elder D, D'Alessio DA, Eyal O, et al. Abnormalities in glucose tolerance are common in children with Fanconi anemia and associated with impaired insulin secretion. Pediatr Blood Cancer 2008; May 2 [Epub ahead of print].
5. Giampietro PF, Verlander PC, Davis JG, et al. Diagnosis of Fanconi anemia in patients without congenital malformations: An International Fanconi Anemia Registry study. Am J Med Genet 1997;68:58-61.
6. Shalitin S, Phillip M, Stein J, et al. Endocrine dysfunction and parameters of the metabolic syndrome after bone marrow transplantation during childhood and adolescence. Bone Marrow Transplant 2007;37:1109-1117.
7. Socie G, Devergie A, Girinski T, et al. Transplantation for Fanconi's Anemia: long-term follow-up of fifty patients transplanted from a sibling donor after low-dose cyclophosphamide and thoraco-abdominal irradiation for conditioning. Br J Haematol 1998;103:249-255.
8. Rose SR. Isolated central hypothyroidism in short stature. Pediatr Res 1995;38:967-973.
9. Butturini A, Bernasconi S, Izzi G, et al. Short stature, Fanconi's Anemia, and risk of leukaemia after growth hormone therapy. The Lancet 1994;343:1576.
10. Spencer CA, Hollowell JG, Kararosyan M, et al. National Health and Nutrition Examination Survey III thyroid-stimulating hormone (TSH)-thyroperoxidase antibody relationships demonstrate that TSH upper reference limits may be skewed by occult thyroid dysfunction. J Clin Endocrinol Metab 2007;92:4236-4240.
11. Baloch Z, Carayon P, Conte-Devolx B, et al. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 2003;13:3-126.
12. Aynsley-Green A, Zachmann M, Werder EA, et al. Endocrine studies in Fanconi's Anemia. Arch Dis Child 1978;53:126-131.
13. Wajnrajch M, Rose SR, Petryk A. Endocrine disorders in Fanconi Anemia. In Fanconi Anemia: Standards for Clinical Care, 2nd Ed Fanconi Anemia Research Fund, Inc.; Eugene, Oregon: 2003. 81-94.
14. Chernausek SD. Mendelian genetic causes of the short child born small for gestational age. J Endocrinol Invest 2006;29:16-20.
15. Saenger P, Czernichow P, Hughes I, et al. Small for gestational age: short stature and beyond. Endocr Rev 2007;28:219-251.
16. Gleadhill V, Bridges JM, Hadden DR. Fanconi's aplastic anemia with short stature. Absence of response to human growth hormone. Arch Dis Child 1975;50:318-320.
17. Sherafat-Kazemzadeh R, Mehta SN, Care MM, et al. Small pituitary size in children with Fanconi anemia. Pediatr Blood Cancer 2007;49:166-170.
18. Cetinkaya E, Asian A, Vidinlisan S, et al. Height improvement by L-thyroxine treatment in subclinical hypothyroidism. Pediatr Int 2003;45:534-537.
19. Papi G, Uberti ED, Betterle C, et al. Subclinical hypothyroidism. Curr Opin Endocrinol Diabetes Obes 2007;14:197-208.
20. Brabant G, Beck-Peccoz P, Jarzab B, et al. Is there a need to redefine the upper normal limit of TSH? Eur J Endocrinol 2006;154:633-6.37.
21. Wartofsky L, Dickey RA. The evidence for a narrower thyrotropin reference range is compelling. J Clin Endocrinol Metab 2005;90:5483-5488.
22. Rose SR, Nisula BC. Circadian variation of thyrotropin in childhood. J Clin Endocrinol Metab 1989;68:1086-1090.
23. Rose SR, Brown RS, Foley T, et al. Update of newborn screening and therapy for congenital hypothyroidism, from the AAP Section on Endocrinology and Committee on Genetics, American Thyroid Association Public Health Committee, and Lawson Wilkins Pediatric Endocrine Society. Pediatrics 2006;117:2290-2303.